Literature DB >> 3486813

Analysis by sequential immunoprecipitations of the specificities of the monoclonal antibodies TU22,34,35,36,37,39,43,58 and YD1/63.HLK directed against human HLA class II antigens.

A Ziegler, J Heinig, C Müller, H Götz, F P Thinnes, B Uchańska-Ziegler, P Wernet.   

Abstract

The monoclonal antibodies (MOABs) TU22, TU34, TU35, TU36, TU37, TU39, TU43, TU58 and YD1/63.HLK were used to identify subpopulations of class II antigens encoded by the human major histocompatibility complex. Since all MOABs reacted with B lymphocytes of HLA-DR1-8 homozygous as well as all heterozygous cells tested, they recognize monomorphic determinants, with the possible exception of TU58 and YD1/63.HLK which do not fix complement. As shown by radioactive binding assays and immunoprecipitations of labeled chains, 3 MOABs reacted strongly and 3 others weakly with isolated beta-chains, and the former also bound alpha-chains, albeit very weakly. Immunoprecipitations with the MOABs from 125I-labeled KR3598 cells (Dw5, DR5, MT2, MB3 homozygous, SB2, SB4) demonstrated that at least 4 different subpopulations of class II antigens were present in the lysate. Possibilities to reconcile these biochemical data with the reactivity of the MOABs with HLA mutant cell lines and with functional as well as tissue distribution studies are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486813     DOI: 10.1016/S0171-2985(86)80019-5

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  15 in total

1.  A ligand-epitope in vitro analysis of major histocompatibility determinants expressed on B and T lymphocytes.

Authors:  N Fernandez; M Kurpisz; M Labeta; J Sachs; G Pawelec
Journal:  Immunology       Date:  1992-09       Impact factor: 7.397

2.  HLA-class II antigens on human hematopoietic progenitors.

Authors:  F W Busch; M Langer; G Pawelec; A Ziegler; P Wernet; H J Bühring; P Meyer; C Müller
Journal:  Blut       Date:  1987-03

3.  Efficient repression of endogenous major histocompatibility complex class II expression through dominant negative CIITA mutants isolated by a functional selection strategy.

Authors:  S Bontron; C Ucla; B Mach; V Steimle
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

4.  [Expression of histocompatibility antigens in human pre-implantation embryos].

Authors:  H H Kessler; G Dohr; G Desoye; R Winter
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

5.  Autoimmune T lymphocytes in myasthenia gravis. Determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene.

Authors:  A Melms; S Chrestel; B C Schalke; H Wekerle; A Mauron; M Ballivet; T Barkas
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

6.  A novel HLA class II molecule.

Authors:  N Fernandez; M O Labeta; H Festenstein
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

7.  [Phenotypic heterogeneity of cardiac myxomas].

Authors:  G A Müller; T Klyscz; J Markovic-Lipkovski; L Seipel; H D Waller
Journal:  Klin Wochenschr       Date:  1987-10-01

8.  In vivo induction of HLA molecules in patients with myeloproliferative syndrome during IFN alpha treatment.

Authors:  C A Müller; J Walz; R Zinser; H J Bühring; B Steinke; H Schmidt
Journal:  Ann Hematol       Date:  1991-11       Impact factor: 3.673

9.  Phenotypic and clinical heterogeneity of CD56-positive acute nonlymphoblastic leukemia.

Authors:  M A Reuss-Borst; B Steinke; H D Waller; H J Bühring; C A Müller
Journal:  Ann Hematol       Date:  1992-02       Impact factor: 3.673

10.  Correlation of interstitial pneumonia with human cytomegalovirus-induced lung infection and graft-versus-host disease after bone marrow transplantation.

Authors:  C A Müller; H Hebart; A Roos; H Roos; M Steidle; H Einsele
Journal:  Med Microbiol Immunol       Date:  1995-10       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.